Report critical of Medicare drug plan costs

Reuters, Oct 15, 2007

Report critical of Medicare drug plan costs

By Lisa Richwine

WASHINGTON (Reuters) -Taxpayers and Medicare patients could have saved almost $15 billion in 2007 if private health insurers had cut expenses for prescription drug coverage and negotiated bigger discounts, a report from Democratic staff of a House of Representatives panel said on Monday.

The Medicare prescription drug benefits offered by private insurers operate with “high administrative costs, sales expenses and profits,” the report said.

Staff for Democrats on the House Oversight and Government Reform Committee, chaired by California Rep. Henry Waxman, based their conclusions on proprietary cost and pricing data obtained from 12 insurers that provide drug coverage to more than 18 million Medicare patients.

“The cost and pricing data obtained by the committee reveal that use of private insurers to deliver Medicare drug coverage is driving up costs and producing only limited savings on drug prices,” the report said.

Aetna Inc, UnitedHealth Group, Humana and other companies offer drug plans through Medicare, the federal health coverage for the elderly and disabled.

Karen Ignagni, president of America’s Health Insurance Plans, said Medicare drug coverage had cost taxpayers and patients less than originally projected and offered more benefits.

“This program has on every level beat expectations,” Ignagni said in an interview. The industry group still is reviewing the report, she said.

The report said administrative expenses, sales costs and profits of private insurers offering Medicare drug plans are almost six times higher than the administrative costs of traditional Medicare coverage, costing almost $5 billion or about $180 per beneficiary in 2007.

The insurers’ profits will account for $1 billion, the report said.

The companies failed to negotiate significant rebates from drug makers, the report also said. Insurers did get discounts in the form of rebates that reduced spending by 8.1 percent in 2007. But that was less than the 26 percent the Medicaid program secured from drug manufacturers. Medicaid is a state and federal insurance program for the poor.

When a Republican-led Congress created the Medicare drug coverage in 2003, supporters said using private insurers would promote competition and cost savings. The benefits took effect in 2006.

Democratic critics have questioned whether private companies can be as efficient and wield as much negotiating power as traditional Medicare.

“Privatizing the delivery of the drug benefit has enriched the drug companies and insurance industry at the expense of seniors and taxpayers,” Waxman said in a statement on Monday. He released the report with 12 Democrats on his committee.

0 Responses to “Report critical of Medicare drug plan costs”

  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s



RSS Gray Panthers in the News

  • An error has occurred; the feed is probably down. Try again later.

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 590 other followers

%d bloggers like this: